Risk factors for progression of age-related macular degeneration
- PMID: 32100327
- PMCID: PMC7155063
- DOI: 10.1111/opo.12675
Risk factors for progression of age-related macular degeneration
Abstract
Purpose: Age-related macular degeneration (AMD) is a degenerative disease of the macula, often leading to progressive vision loss. The rate of disease progression can vary among individuals and has been associated with multiple risk factors. In this review, we provide an overview of the current literature investigating phenotypic, demographic, environmental, genetic, and molecular risk factors, and propose the most consistently identified risk factors for disease progression in AMD based on these studies. Finally, we describe the potential use of these risk factors for personalised healthcare.
Recent findings: While phenotypic risk factors such as drusen and pigment abnormalities become more important to predict disease progression during the course of the disease, demographic, environmental, genetic and molecular risk factors are more valuable at earlier disease stages. Demographic and environmental risk factors such as age and smoking are consistently reported to be related to disease progression, while other factors such as sex, body mass index (BMI) and education are less often associated. Of all known AMD variants, variants that are most consistently reported with disease progression are rs10922109 and rs570618 in CFH, rs116503776 in C2/CFB/SKIV2L, rs3750846 in ARMS2/HTRA1 and rs2230199 in C3. However, it seems likely that other AMD variants also contribute to disease progression but to a lesser extent. Rare variants have probably a large effect on disease progression in highly affected families. Furthermore, current prediction models do not include molecular risk factors, while these factors can be measured accurately in the blood. Possible promising molecular risk factors are High-Density Lipoprotein Cholesterol (HDL-C), Docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), zeaxanthin and lutein.
Summary: Phenotypic, demographic, environmental, genetic and molecular risk factors can be combined in prediction models to predict disease progression, but the selection of the proper risk factors for personalised risk prediction will differ among individuals and is dependent on their current disease stage. Future prediction models should include a wider set of genetic variants to determine the genetic risk more accurately, and rare variants should be taken into account in highly affected families. In addition, adding molecular factors in prediction models may lead to preventive strategies and personalised advice.
Keywords: age-related macular degeneration; epidemiology; genetics.
© 2020 The Authors. Ophthalmic and Physiological Optics published by John Wiley & Sons Ltd on behalf of College of Optometrists.
Conflict of interest statement
The author(s) have no proprietary or commercial interest in any materials discussed in this article.
Figures









Similar articles
-
Risk Prediction for Progression of Macular Degeneration: 10 Common and Rare Genetic Variants, Demographic, Environmental, and Macular Covariates.Invest Ophthalmol Vis Sci. 2015 Apr;56(4):2192-202. doi: 10.1167/iovs.14-15841. Invest Ophthalmol Vis Sci. 2015. PMID: 25655794 Free PMC article.
-
Prevalence of age-related macular degeneration associated genetic risk factors and 4-year progression data in the Irish population.Br J Ophthalmol. 2018 Dec;102(12):1691-1695. doi: 10.1136/bjophthalmol-2017-311673. Epub 2018 Feb 16. Br J Ophthalmol. 2018. PMID: 29453225
-
Growth of geographic atrophy on fundus autofluorescence and polymorphisms of CFH, CFB, C3, FHR1-3, and ARMS2 in age-related macular degeneration.JAMA Ophthalmol. 2014 May;132(5):528-34. doi: 10.1001/jamaophthalmol.2013.8175. JAMA Ophthalmol. 2014. PMID: 24557084 Clinical Trial.
-
Prevention and treatment of age-related macular degeneration: an update for pharmacists.Consult Pharm. 2013 Nov;28(11):723-37. doi: 10.4140/TCP.n.2013.723. Consult Pharm. 2013. PMID: 24217192 Review.
-
Genotype-Phenotype Correlations and Genetic Risk Assessment in Age-Related Macular Degeneration.Adv Exp Med Biol. 2025;1468:21-25. doi: 10.1007/978-3-031-76550-6_4. Adv Exp Med Biol. 2025. PMID: 39930167 Review.
Cited by
-
Galectins in the Pathogenesis of Common Retinal Disease.Front Pharmacol. 2021 May 17;12:687495. doi: 10.3389/fphar.2021.687495. eCollection 2021. Front Pharmacol. 2021. PMID: 34079467 Free PMC article. Review.
-
Small hard drusen and associated factors in early seniority.PLoS One. 2022 Dec 22;17(12):e0279279. doi: 10.1371/journal.pone.0279279. eCollection 2022. PLoS One. 2022. PMID: 36548342 Free PMC article.
-
A Screening Tool for Self-Evaluation of Risk for Age-Related Macular Degeneration: Validation in a Spanish Population.Transl Vis Sci Technol. 2022 Jun 1;11(6):23. doi: 10.1167/tvst.11.6.23. Transl Vis Sci Technol. 2022. PMID: 35749108 Free PMC article.
-
Transcriptomic and proteomic retinal pigment epithelium signatures of age-related macular degeneration.Nat Commun. 2022 Jul 26;13(1):4233. doi: 10.1038/s41467-022-31707-4. Nat Commun. 2022. PMID: 35882847 Free PMC article.
-
Progress in Stem Cells-Based Replacement Therapy for Retinal Pigment Epithelium: In Vitro Differentiation to In Vivo Delivery.Stem Cells Transl Med. 2023 Aug 16;12(8):536-552. doi: 10.1093/stcltm/szad039. Stem Cells Transl Med. 2023. PMID: 37459045 Free PMC article. Review.
References
-
- Wong WL, Su X, Li X, et al. Global prevalence of age‐related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta‐analysis. Lancet Glob Health 2014; 2: e106–116. - PubMed
-
- Tomany SC, Wang JJ, Van Leeuwen R, et al. Risk factors for incident age‐related macular degeneration: pooled findings from 3 continents. Ophthalmology 2004; 111: 1280–1287. - PubMed
-
- Schaal KB, Rosenfeld PJ, Gregori G, Yehoshua Z & Feuer WJ. Anatomic clinical trial endpoints for nonexudative age‐related macular degeneration. Ophthalmology 2016; 123: 1060–1079. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous